Partnership

A number of cooperative activities are ongoing with biotechnological and pharmaceutical companies focusing on RNAi research and RNAi drug development.

Academic collaborations

Riboxx has ongoing cooperative relationships with the Dresden University of Technology (Technische Universität Dresden), the Center for Regenerative Diseases Dresden (CRTD), the University Hospital of Dresden (Universitätsklinikum Dresden), the University Cancer Research Center Dresden (Universitäts KrebsCentrum Dresden), the Oncoray Research Center, and the Max-Planck Institute of Molecular Cell Biology and Genetics, located in Dresden (MPI-CBG).

Riboxx has very strong relationships with leading scientific groups in the field of cell biology, hematology-oncology, and infectious diseases. The scientists at Riboxx are in close contact with the scientists in academe, the objective being the development of RNAi tools to suit their needs.